Cognitive Behavioural Therapy for Obesity
A Maintenance-Oriented Cognitive Behavioural Therapy in the Treatment of Obesity
1 other identifier
interventional
24
1 country
1
Brief Summary
The purpose of this study is to evaluate the effectiveness of a cognitive behavioural treatment (CBT) designed to help obese patients lose weight and to maintain their weight losses over time. It is hypothesized that CBT will result in greater sustained weight loss.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2 obesity
Started Mar 2006
Typical duration for phase_2 obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2006
CompletedFirst Posted
Study publicly available on registry
February 20, 2006
CompletedStudy Start
First participant enrolled
March 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2008
CompletedJuly 3, 2008
July 1, 2008
2 years
February 16, 2006
July 1, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight
baseline, post-treatment, one-year follow-up
Secondary Outcomes (1)
obesity-specific quality of life, mood disturbance, eating disturbance, cognitive disturbance
baseline, post-treatment, one-year follow-up
Study Arms (1)
1
OTHER20 weekly sessions of CBT integrated with motivational enhancement strategies
Interventions
20 weekly sessions of CBT integrated with motivational enhancement strategies
Eligibility Criteria
You may qualify if:
- The participants will be recruited from among patients referred to the Metabolism and Obesity Service of Royal Prince Alfred Hospital.
You may not qualify if:
- psychiatric conditions (i.e., current psychosis, severe depression, mental retardation, and drug or alcohol abuse)
- or physical conditions (i.e., significant hepatic or renal dysfunction and significant cardiovascular disease such as heart failure, stroke and transient ischaemic attacks) that would preclude full participation in the study;
- current treatment for obesity;
- current treatments known to affect eating or weight (e.g., medications);
- pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Metabolism and Obesity Services, Royal Prince Alfred Hospital
Sydney, New South Wales, 2050, Australia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth Rieger, PhD
University of Sydney
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 16, 2006
First Posted
February 20, 2006
Study Start
March 1, 2006
Primary Completion
March 1, 2008
Study Completion
March 1, 2008
Last Updated
July 3, 2008
Record last verified: 2008-07